Schedule 13G ownership disclosure

CG oncology Inc

Common stock, $0.0001 par value per share · CUSIP: 156944100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Unique Diamond Investments Limited

    Shares: 586,982 · Class: 0.8%

  • ORI Healthcare Fund, L.P.

    Shares: 586,982 · Class: 0.8%

  • ORI Capital Inc.

    Shares: 586,982 · Class: 0.8%

  • ORI Capital Holding Inc.

    Shares: 586,982 · Class: 0.8%

  • Charming Jade Limited

    Shares: 3,003,931 · Class: 4%

  • ORI Healthcare Fund II, L.P.

    Shares: 3,003,931 · Class: 4%

  • ORI Capital II Inc.

    Shares: 3,003,931 · Class: 4%

  • ORI Holding II Inc.

    Shares: 3,003,931 · Class: 4%

  • Healthcare Seed Limited

    Shares: 3,590,913 · Class: 4.7%

  • SONG, Hong Fang

    Shares: 4,211,341 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-009941
Form type
SCHEDULE 13G/A
Filer
CG Oncology, Inc.
CIK
CIK 1991792
Filed
Jan 28, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub